搜尋
Mckesson Corp
MCK添加自選
764.030USD
+19.180+2.58%
收盤 06/23, 16:00（美東）報價延遲15分鐘
89.44B總市值
19.83本益比TTM
關鍵數據
762.780今開
768.750最高
1.36M成交量
19.83本益比TTM
18.03本益比動
3.170股利TTM
1.11%換手率
744.850昨收
754.490最低
553.71M成交額
28.52本益比靜
-72.40市淨率
0.41%股息率 TTM
6.48%ROA
999.00052週最高
1.05量比
3.29B淨利潤
123.00M總股本
38.5275每股盈餘TTM
0.33Beta
--ROE
637.00052週最低
1.91%振幅
4.20%毛利率
89.44B總市值
-1.86回報/風險
1.49%風險率
TradingKey Mckesson Corp股票評分
單位: USD 更新時間: 2026-06-23操作建議
Mckesson Corp當前公司基本面數據相對穩定，增長潛力很大。當前估值合理，在藥品行業排名4/157位。機構持股佔比非常高，近一月多位分析師給出公司評級為買入。最高目標價為932.82。中期看，股價處於下降通道。近一個月，市場表現一般，但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間，可以做區間波段操作。
Mckesson Corp評分
壓力支撐
由於公司未披露，未能獲取相關數據
多維評測
本期評分
上期評分
公司輿情
過去24小時
熱度
38°C
過冷
過熱
看空
Mckesson Corp亮點
亮點風險
McKesson Corporation is a diversified healthcare services company, which focuses on advancing health outcomes for patients everywhere. Its U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products in the United States (U.S.). The Prescription Technology Solutions (RxTS) segment helps solve medication access, affordability and adherence challenges for patients by working across healthcare to connect patients, pharmacies, pharmacy benefit managers, health plans, and biopharma companies. The Medical-Surgical Solutions provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, hospital reference labs, and home healthcare agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Canada and Norway. It also offers oncology and specialty solutions.
行業龍頭
公司營業收入處於行業前列，最新年度總收入403.43B美元
業績高增長
公司營業收入穩步增長，連續3年增長30.58%
利潤高增長
公司淨利潤處於行業前列，最新年度總收入403.43B美元
高分紅
公司屬於高分紅公司，最新股息支付率10.68%
估值低估
公司最新PE估值19.83，處於3年歷史低位
機構減倉
最新機構持股112.82M股，環比減少2.46%
史蒂夫·曼德爾持倉
明星投資者史蒂夫·曼德爾持倉，最新持倉448.68K股
分析師目標
基於
19
分析師
買入
評級
932.815
目標均價
+25.24%
漲幅空間
數據免責聲明：分析師評級與目標價由LSEG提供，僅供參考，不應當作投資建議
Mckesson Corp新聞
即將為您帶來更多新聞，敬請期待。 。 。
財務指標
每股收益
由於公司未披露，未能獲取相關數據
營業總收入
由於公司未披露，未能獲取相關數據
Mckesson Corp簡介
McKesson Corporation is a diversified healthcare services company, which focuses on advancing health outcomes for patients everywhere. Its U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products in the United States (U.S.). The Prescription Technology Solutions (RxTS) segment helps solve medication access, affordability and adherence challenges for patients by working across healthcare to connect patients, pharmacies, pharmacy benefit managers, health plans, and biopharma companies. The Medical-Surgical Solutions provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, hospital reference labs, and home healthcare agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Canada and Norway. It also offers oncology and specialty solutions.
公司代碼MCK
公司Mckesson Corp
CEOTyler (Brian Scott)
網址https://www.mckesson.com/
相關品種
+0.54%
+3.37%
+2.07%
+2.98%
+3.54%
+2.60%
+0.66%
+3.33%
+0.14%
-1.44%
+0.32%
+1.53%
+2.59%
-0.36%
0.00%
+0.90%
-5.50%
+2.77%
+2.33%熱門品種
72.199
-0.746 (-1.02%)
294.300
-2.710 (-0.91%)
200.040
-8.610 (-4.13%)
4088.210
-22.540 (-0.55%)
670.750
-61.870 (-8.45%)
1961.070
-312.660 (-13.75%)
1051.770
-159.610 (-13.18%)
346.130
-3.550 (-1.02%)
62674.000
+233.300 (+0.37%)
381.610
-23.440 (-5.79%)
常見問題
Mckesson Corp(MCK)的當前股價是多少？
Mckesson Corp(MCK)的當前股價是 764.03。
Mckesson Corp 的股票代碼是什麼？
Mckesson Corp的股票代碼是MCK。
Mckesson Corp股票的52週最高點是多少？
Mckesson Corp股票的52週最高點是999.00。
Mckesson Corp股票的52週最低點是多少？
Mckesson Corp股票的52週最低點是637.00。
Mckesson Corp的市值是多少？
Mckesson Corp的市值是93.98B。
現在Mckesson Corp(MCK)的股票是買入、持有還是賣出？
根據分析師評級，Mckesson Corp(MCK)的總體評級為買入，目標價格為932.82。
Mckesson Corp(MCK)股票的每股收益（EPS TTM）是多少
Mckesson Corp(MCK)股票的每股收益（EPS TTM）是38.53。
